Sign in to continue:

Friday, March 20th, 2026

Vivakor Receives Nasdaq Panel Approval for Continued Listing Pending $1.00 Bid Price Compliance by April 30, 2026




Vivakor Receives Nasdaq Panel Approval for Path to Continued Listing

Vivakor Granted Path to Regain Nasdaq Listing, Subject to Compliance by April 30, 2026

Key Highlights

  • Nasdaq Panel Approves Path to Continued Listing: Vivakor, Inc. has been granted a conditional path to retain its listing on The Nasdaq Capital Market, provided it regains compliance with Nasdaq’s \$1.00 minimum bid price requirement by April 30, 2026.
  • Bid Price Rule: To comply, the closing bid price of Vivakor’s common stock must be \$1.00 or greater for at least ten consecutive trading days.
  • Reinstatement and Monitoring: Upon successful compliance, Vivakor’s stock will be reinstated for trading on the Nasdaq Capital Market and will be subject to a one-year Mandatory Panel Monitor period.
  • Public Reprimand: The Nasdaq Hearings Panel also issued a Public Reprimand Letter to Vivakor for issuing shares in excess of 19.99% of its common stock in certain financings without required shareholder approval, in violation of Nasdaq Listing Rules.

Details and Implications for Shareholders

Vivakor, Inc. (OTC: VIVK), an integrated energy transportation, storage, reuse, and remediation company, announced that the Nasdaq Hearings Panel has approved a plan that allows the company to regain its Nasdaq listing—if and only if it meets the \$1.00 minimum closing bid price for ten consecutive days by April 30, 2026.

If Vivakor achieves this, its stock will be reinstated to trade on the Nasdaq Capital Market. However, after reinstatement, it will be subject to a one-year Mandatory Panel Monitor, during which it must continue to comply with Nasdaq’s rules and requirements.

Price-sensitive and Shareholder-Relevant Information:

  • The Panel’s decision is a significant development that provides a clear timeline and pathway back to Nasdaq trading. A return to Nasdaq could increase liquidity, visibility, and potentially the share price, making this a highly price-sensitive event.
  • The company’s failure to obtain shareholder approval before issuing shares exceeding 19.99% of its outstanding common stock for certain financings was publicly reprimanded by the Panel. This is a critical governance issue that shareholders should be aware of, as it may impact investor confidence and regulatory scrutiny.

Management Commentary

Vivakor Chairman and CEO James Ballengee expressed appreciation for the Nasdaq Panel’s decision, emphasizing the company’s focus on executing its strategy, restoring trading on Nasdaq, and building value across its integrated energy transportation and infrastructure platform.

About Vivakor, Inc.

Vivakor operates one of the largest oilfield trucking fleets in the continental United States, providing sustainable energy transportation, storage, reuse, and remediation services. Its mission is to develop and operate assets and technologies in the energy sector, with long-term contracts for crude oil and produced water logistics. The company’s oilfield waste remediation facilities are designed to facilitate the recovery, reuse, and disposal of petroleum byproducts and oilfield waste.

For more information: http://vivakor.com

Forward-Looking Statements and Risks

Investors should note that this announcement contains forward-looking statements based on management’s expectations, which are subject to significant business, economic, regulatory, and market risks. Actual outcomes may differ materially from those expressed or implied. Risks include, but are not limited to, the company’s ability to maintain Nasdaq listing, complete planned acquisitions, regulatory approvals, market volatility, changes in regulation and tax laws, and overall economic conditions.

Investors are encouraged to review Vivakor’s filings with the Securities and Exchange Commission for a full discussion of risk factors.

Investor Contact


Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. All forward-looking statements are subject to risks and uncertainties. Investors should conduct their own due diligence and consult with their financial advisors before making any investment decisions.




View Vivakor, Inc. Historical chart here



Shattuck Labs, Inc. 2025 Annual Report: Regulatory, Clinical, and Compliance Overview for Biopharmaceuticals

Shattuck Labs, Inc. 2025 Annual Report – Key Investor Highli...

Donaldson Company Q2 2026 Earnings Report: Segment Performance, Revenue Changes, and Financial Highlights

Donaldson Company, Inc. Reports Second Quarter Fiscal 2026 R...

   Ad